Cargando…
Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study
BACKGROUND: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by a predisposition to develop multiple benign tumors. A major feature of NF1 is the development of localized cutaneous neurofibromas. Cutaneous neurofibromas manifest in > 99% of adults with NF1 and are responsible fo...
Autores principales: | Cannon, Ashley, Chen, Mei-Jan, Li, Peng, Boyd, Kevin P., Theos, Amy, Redden, David T., Korf, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803843/ https://www.ncbi.nlm.nih.gov/pubmed/29415745 http://dx.doi.org/10.1186/s13023-018-0772-z |
Ejemplares similares
-
Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
por: Cunha, Karin SG, et al.
Publicado: (2014) -
Clinical trial design for cutaneous neurofibromas
por: Cannon, Ashley, et al.
Publicado: (2018) -
Treatment of Cutaneous Neurofibromas in Patients with Neurofibromatosis Type 1
por: Wozniak, Bartosz, et al.
Publicado: (2023) -
Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1
por: Rozza-de-Menezes, Rafaela E., et al.
Publicado: (2017) -
Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1
por: Yasuda, Ken‐ichi, et al.
Publicado: (2020)